Press Releases and Statements

CHPA Senior Vice President of Dietary Supplements Duffy MacKay released the following statement today in response to a recent JAMA Network Open Study investigating the prevalence and characteristics of U.S. adults consuming botanicals potentially linked to liver toxicity:

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) today released the following statement after providing input to U.S. House Energy & Commerce Committee Members, U.S. Representatives Larry Bucshon (IN-08) and Diana DeGette (CO-01), following their request for information from industry stakeholders on how Congress can build upon the 21st Century Cures Act and Cures 2.0 to develop and deliver a new generation of treatments:

Consumer Healthcare Products Association (CHPA) President & CEO Scott Melville released the following statement today in response to U.S. Senator Dick Durbin introducing the Dietary Supplement Listing Act:

The Consumer Healthcare Products Association (CHPA), the leading voice advocating to empower self-care by preserving and expanding access to trusted consumer healthcare products, today released the following statement in recognition of International Self-Care Day, which is recognized annually on July 24:

The Consumer Healthcare Products Association today released the following statement after joining 17 other members of the Health Choices Coalition – a group comprised of healthcare providers, patients, consumers, retailers, manufacturers, pharmacies, insurers, and businesses of all sizes – in sending a letter of support to sponsors of the Oral Health Products Inclusion Act (H.R. 8599). This legislation would increase access to everyday over-the-counter (OTC) oral care products by allowing them to be purchased with Flexible Spending Account (FSA) and Health Savings Account (HSA) funds as “qualified medical expenses.”

(WASHINGTON, D.C.) — Today, the Consumer Healthcare Products Association (CHPA), the national trade association representing the leading manufacturers and marketers of consumer healthcare products, announced the addition of 15 new members, four manufacturers and 11 associate members, from the last quarter. This continues a strong growth trajectory of diverse self-care companies joining the association. CHPA also recognized several of its member companies for reaching significant membership milestone anniversaries this year.

CHPA Senior Vice President of Legal, Government Affairs & Policy David Spangler released the below statement today following the U.S. Supreme Court’s decision to overturn the Chevron standard, a principle of judicial deference used by federal courts for nearly four decades when reviewing a federal agency’s interpretation of a statute it administers:

(WASHINGTON, D.C.) The Consumer Healthcare Products Association (CHPA) today announced the election of new members to its board of directors during the association’s summer meeting this week in Washington.

CHPA and several of its member companies who manufacture and market leading over-the-counter oral care products, including Colgate-Palmolive, Haleon, Kenvue, Lornamead, Procter & Gamble, and Sanofi, joined Members of Congress on Capitol Hill this week to celebrate the introduction of HR 8599, the Oral Health Products Inclusion Act. 

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) released the below statement today applauding the passage of H.R. 2964, the Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act in the U.S. House of Representatives.

CHPA released the following statement today applauding the introduction of HR 8599, the Oral Health Products Inclusion Act. This bipartisan legislation, sponsored by U.S. Reps. Jeff Van Drew (NJ-02), Brad Schneider (IL-10), Nicole Malliotakis (NY-11), and Jimmy Panetta (CA-19), would increase access to certain oral care items, including manual and electric toothbrushes, water flossers, anti-cavity toothpaste, mouthwash, and similar oral care products by recognizing them as “qualified medical expenses” that can be purchased with Flexible Spending Account (FSA) and Health Savings Account (HSA) funds. Extending eligibility to oral care products so Americans can better manage their unique oral care needs builds upon a previous bipartisan victory in 2020, which reinstated FSA/HSA eligibility for OTC medicines, and for the first time, feminine care products, as part of the Coronavirus Aid, Relief, and Economic Security (CARES) Act.

(Washington, D.C.) – Today, the Consumer Healthcare Products Association (CHPA) released the following statement after submitting comments to the U.S. Food and Drug Administration (FDA) in response to draft guidance the Agency released in April on New Dietary Ingredient Notification (NDIN) Master Files for Dietary Supplements: